“…Demographics of the study population Total patients 16 Gender 14 female, 2 male Fitzpatrick skin phototype Type I: 1 Type II: 6 Type III: 9 Age (average + SD) 48.2 + 7.7 y Age at rosacea onset (average + SD) 35.3 + 12.4 y PDL is lessened. [9][10][11] The KTP laser may be used to treat discrete, larger-caliber telangiectasia; however, this laser is limited to treating clinically visible telangiectasia, and has not been reported to improve the background erythema as well as the PDL. Intense pulsed light is a broadband-filtered white light technology operating in the millisecond domain that has undergone preliminary use in treating rosacea.…”
Section: Discussionmentioning
confidence: 98%
“…In one study using a subjective estimate of the percentage reduction in rosacea-associated telangiectasias after a single 595-nm PDL treatment using a 6-millisecond pulse duration and subpurpuric fluences, only 33% of patients achieved greater than 50% improvement. 9 Tanghetti and Sherr 10 used the 595-nm PDL to treat telangiectasia with a pulse width of 40 milliseconds, fluences at or below the purpuric threshold, and multiple passes. All of the vessels that cleared were associated with transient purpura, whereas subpurpuric fluences did not provide acceptable vessel clearance.…”
Section: Laser Treatment Of Cutaneous Vasculaturementioning
“…Demographics of the study population Total patients 16 Gender 14 female, 2 male Fitzpatrick skin phototype Type I: 1 Type II: 6 Type III: 9 Age (average + SD) 48.2 + 7.7 y Age at rosacea onset (average + SD) 35.3 + 12.4 y PDL is lessened. [9][10][11] The KTP laser may be used to treat discrete, larger-caliber telangiectasia; however, this laser is limited to treating clinically visible telangiectasia, and has not been reported to improve the background erythema as well as the PDL. Intense pulsed light is a broadband-filtered white light technology operating in the millisecond domain that has undergone preliminary use in treating rosacea.…”
Section: Discussionmentioning
confidence: 98%
“…In one study using a subjective estimate of the percentage reduction in rosacea-associated telangiectasias after a single 595-nm PDL treatment using a 6-millisecond pulse duration and subpurpuric fluences, only 33% of patients achieved greater than 50% improvement. 9 Tanghetti and Sherr 10 used the 595-nm PDL to treat telangiectasia with a pulse width of 40 milliseconds, fluences at or below the purpuric threshold, and multiple passes. All of the vessels that cleared were associated with transient purpura, whereas subpurpuric fluences did not provide acceptable vessel clearance.…”
Section: Laser Treatment Of Cutaneous Vasculaturementioning
“…The PDL has an unparalleled safety record and has been used to treat portwine stains for over two decades [8][9][10][11][12]. Treatment of rosacea with the PDL has been shown to improve not only the telangiectasias and erythema, but also the symptoms associated with rosacea [13][14][15][16][17][18]. Although purpura-free removal of cutaneous vessels has been documented using pulse-durations of 6 and 10 milliseconds [6,14], the use of two separate settings in the current study enabled optimal treatment of linear vessels and diffuse erythema, while reducing but not eliminating purpura in all subjects.…”
The high-energy, long pulse-duration pulsed-dye laser improves rosacea with a very favorable safety profile, and less purpura than resulted from earlier generation pulsed-dye lasers.
“…Its major drawback is purpura generation (2,5). There are many studies demonstrating this laser's effi cacy on the treatment of the vascular component of rosacea but very few establishing its effi cacy on quality of life improvement.…”
This study reinforces the idea that pulsed dye laser usage for the treatment of erythematotelangiectatic rosacea is very efficient, emphasizing that it also has the ability to improve rosacea patients' quality of life.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.